Difficulty: Medium
Average Score: 91%
Practice
Which of the following drugs is added to levodopa therapy of parkinsonism to attenuate wearing-off effect?
Correct answer
A
Rationale
In the pharmacological management of Parkinsonism, the wearing-off effect refers to the phenomenon where the therapeutic effects of levodopa diminish over time, leading to a return of symptoms. Selegiline, the correct answer, is added to levodopa therapy to help attenuate this wearing-off effect. Selegiline is a monoamine oxidase type B (MAO-B) inhibitor that works by increasing dopamine levels in the brain, thus prolonging the effects of levodopa.
Trihexyphenidyl (option B) is an anticholinergic agent used to treat tremors and muscle stiffness in Parkinson's disease but does not specifically address the wearing-off effect. Amantadine (option C) is an antiviral agent that also has mild anti-Parkinsonian effects but is not primarily used to attenuate the wearing-off effect of levodopa.
In an educational context, understanding the rationale behind adding specific drugs to levodopa therapy in Parkinsonism is crucial for healthcare professionals to optimize patient care. By knowing the mechanisms of action and specific indications of each drug, practitioners can tailor treatment plans to address individual patient needs effectively. This knowledge helps in providing comprehensive care and improving patient outcomes in the management of Parkinsonism.
Trihexyphenidyl (option B) is an anticholinergic agent used to treat tremors and muscle stiffness in Parkinson's disease but does not specifically address the wearing-off effect. Amantadine (option C) is an antiviral agent that also has mild anti-Parkinsonian effects but is not primarily used to attenuate the wearing-off effect of levodopa.
In an educational context, understanding the rationale behind adding specific drugs to levodopa therapy in Parkinsonism is crucial for healthcare professionals to optimize patient care. By knowing the mechanisms of action and specific indications of each drug, practitioners can tailor treatment plans to address individual patient needs effectively. This knowledge helps in providing comprehensive care and improving patient outcomes in the management of Parkinsonism.